建構無障礙用藥環境：視障族群友善藥事照護需求初探

Abstract

根據衛生福利部公告之《105年身心障礙者生活狀況及需求調查報告》，截至105年6月底，國內視覺障礙者人數有57,118人，有36.43%的視覺障礙族群有服藥上的困難，可見視障者的用藥安全是迫切需要被關注的議題。 本研究為質性研究，研究者透過焦點團體座談以及半結構訪談的方式探索視障者用藥經驗、感受與期待。在研究中發現，視障者的用藥歷程從藥品辨識、正確服藥、藥品管理與儲存以及用藥資訊的取得都充滿了挑戰與限制。而這樣的限制並不能全然歸因於視障者本身的視力限制，而是因此在這「致障」用藥環境中，缺乏藥品資訊易讀性的設計、醫藥人員對視障需求的敏感度不足以及取得藥事照護資源的可近性低等。 為了改善上述問題，除了推動藥品資訊易讀性的政策之外，藥事團體應與視障團體合作，評估國內障礙者用藥的處境、需求並制定相關無障礙藥事照護指引；而在藥師在執業過程中應能辨識視障者需求、精進諮詢以及溝通的技巧，並以提高視障者用藥自主性為目標提供個人化的藥事照護。透過多方的合作增進藥事照護資源取得的平等性，更保障視障族群有更安全的用藥環境。

Abstract According to “Report on the Living Conditions and Needs of Persons with Disabilities in 2016” by the Ministry of Health and Welfare, as of the end of June 2016, there were 57,118 people with visual impairment in Taiwan, and 36.43% of the visually impaired people had difficulty in taking medication. Medication safety for visually impaired people needs urgent attention. This qualitative study explores the experience, feelings and expectations regarding medication for the visually impaired. Data is collected through focus groups and semi-structured interviews. The study finds that the medication use of visually impaired person full of challenges, including pill identification, correct medication, medication management and storage, and access to medication information. The difficulty is not merely a result of their own visual impairment. Instead, it is also the consequence of the 'disability-causing' medication environment causing by the lack of legible drug information and insensitivity of medical personnel to the needs of visual impairment. The accessibility of medical are resources is low. To improve these problems in addition to the policy of promoting readable medication information, pharmaceutical groups should cooperate with visually impaired groups to assess their needs and formulate relevant barrier-free pharmaceutical care guidelines. In so doing, we can improve consultation and communication skills, and provide personalized pharmaceutical care to facilitate the independence of medication for visually impaired persons. Through multi-party cooperation, the equality of pharmaceutical care resources can be improved, and build a safer medication environment for all.